Literature DB >> 35293624

Inclusive education for children with disabilities in a refugee camp.

Thomas M Crea1, Kerri Evans2, Robert G Hasson3, Sarah Neville4, Kelsey Werner5, Elizabeth Wanjiku6, Nobert Okumu7, Gregory St Arnold8, Eric Velandria9, Daniela Bruni10.   

Abstract

Children in refugee camps, and particularly those with disabilities, face unique challenges in accessing education and are at high risk of being marginalised. Best practices suggest that main-streaming is the optimal strategy for serving students with disabilities. This study examines the extent to which mainstreaming in a refugee camp helps to promote children's prosocial behaviours, taking into account their emotional and behavioural problems. In Kakuma Refugee Camp, Kenya, researchers collected data from the parents of children currently enrolled in special needs education centres (n=65) and from those formerly enrolled at these facilities who transitioned to mainstream classrooms (n=81). Children in mainstream schools functioned better in terms of prosocial behaviours, but this relationship disappeared when factoring in children's emotional and behavioural difficulties. In the context of a refugee camp, mainstreaming alone is not likely to help children's psychosocial and educational functioning, which requires dedicated supports, appropriate facilities and infrastructure, and a dual focus on disability-specific and disability-inclusive initiatives.
© 2022 ODI.

Entities:  

Keywords:  educational inclusion; forced displacement; mainstreaming; refugee camps; refugees; special needs education

Year:  2022        PMID: 35293624     DOI: 10.1111/disa.12534

Source DB:  PubMed          Journal:  Disasters        ISSN: 0361-3666


  1 in total

1.  Inclusive education in a refugee camp for children with disabilities: How are school setting and children's behavioral functioning related?

Authors:  Thomas M Crea; Elizabeth K Klein; Oladoyin Okunoren; Maria Paula Jimenez; Greg St Arnold; Truphena Kirior; Eric Velandria; Daniela Bruni
Journal:  Confl Health       Date:  2022-10-13       Impact factor: 4.554

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.